Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-3-yl)-2-fluorophenyl)-3-phenylurea | Patent Number 11612591

US 11612591 B2
Application Number17735820
Publication NumberUS 20220257574 A1
Pendency10 months, 29 days
Filled DateMay 3, 2022
Priority DateDec 30, 2019
Publication DateAug 18, 2022
Expiration DateDec 29, 2039
Inventor/ApplicantsScott Bone
Fred Jordan
Michael D. Kaufman
Corey Bloom
ExaminesALLEY, GENEVIEVE S
Art Unit1617
Technology Center1600
Assignments
Deciphera Pharmaceuticals Llc
Current
Deciphera Pharmaceuticals Llc
Original
Law Firm
You must be logged in to view
Login
Attorneys
Subscription-Only
View Concierge Program
See the invalidated claims, subscribe to our Concierge Program.
View Concierge Program
Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.
Check our Latest ReportPurchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.